Aptiom (eslicarbazepine acetate) is Once-Daily Treatment in Four Tablet Strengths
Tuesday, April 8, 2014

Aptiom (eslicarbazepine acetate), a once daily antiepilepsy drug (AED) used to treat partial-onset seizures is now available in pharmacies. The Food and Drug Administration approved the drug in November 2013. Manufacturer Sunovion Pharmaceuticals is making Aptiom available in four tablet strengths (200mg, 400mg, 600mg and 800mg).

“The 30 percent of people with epilepsy who have persistent seizures despite the use of other medications are very much looking forward to the availability of the new anti-seizure medication eslicarbazepine,” said Nathan Fountain, MD, Chair of the Epilepsy Foundation Professional Advisory Board.

For more on eslicarbazepine acetate.